Medicaid is required to cover almost all drugs, but Congress specifically excluded those for weight loss. Even so, 16 states now cover Wegovy. Others are considering it, but it could strain budgets.
For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been ...
more than 320 drugs are on the drug shortage list maintained by the University of Utah Drug Information Service. Dr. Ethan Blocher-Smith Physicians who treat patients with diabetes and obesity say ...
Physicians see Wegovy and other drugs like it as powerful treatments for obesity as well as its many related health consequences. Analysts forecast annual sales of this new class of medicines to ...
(CNN) - About one in eight adults said they have taken a GLP-1 drug like Ozempic or Mounjaro, according to a new poll from ...
The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while the remaining 38 percent they took the medications just to lose ...
Mr. Hari is a British journalist and the author of “Magic Pill: The Extraordinary Benefits — and Disturbing Risks — of the New Weight Loss Drugs.” Ever since I was a teenager, I have ...
Even if they're not acquired, these small companies are developing promising obesity ... add up to a nice investment opportunity. First, corporate buyouts are back in style. Second, weight-loss ...
(AP Photo/Amanda Andrade-Rhoades, File) Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like ... It’s an essential part of a healthy community ...
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the ...
Update RequiredTo play audio, update browser or Flash plugin. Copyright 2024 NPR. To see more, visit https://www.npr.org. Medicaid is required to cover almost all ...
(CNN) — About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity ... application to add cardiovascular benefits to the medicine’s label. GLP-1 medications such ...